Inventor · disambiguated record
Ziqing Qian
Also filed as: QIAN ZIQING
14 granted patents·20 pending applications·95 citations·filing 2015–2025
91Inventor score
Top patents by PatentIndex Score
34 records- 0197US11225506B2Cell penetrating peptides and methods of making and using thereofENTRADA THERAPEUTICS INC·Filed 2020·Granted Jan 18, 2022·14 cites·41 claims
- 0296US11878046B2Di-sulfide containing cell penetrating peptides and methods of making and using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2021·Granted Jan 23, 2024·4 cites·18 claims
- 0396US10815276B2Cell penetrating peptides and methods of making and using thereofENTRADA THERAPEUTICS INC·Filed 2016·Granted Oct 27, 2020·14 cites·40 claims
- 0496US10626147B2Cell penetrating peptides and methods of making and using thereofENTRADA THERAPEUTICS INC·Filed 2015·Granted Apr 21, 2020·39 cites·22 claims
- 0594US11987821B2Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathyENTRADA THERAPEUTICS INC·Filed 2021·Granted May 21, 2024·2 cites·18 claims
- 0694US11351222B2Di-sulfide containing cell penetrating peptides and methods of making and using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Jun 7, 2022·7 cites·18 claims
- 0794US11352394B2Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Jun 7, 2022·8 cites·26 claims
- 0892US12454552B2Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2022·Granted Oct 28, 2025·1 cites·7 claims
- 0992US11168310B2Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathyENTRADA THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·6 cites·35 claims
- 1084US2025011367A1Cell penetrating peptides and methods of making and using thereofENTRADA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1182US2025115885A1Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathyENTRADA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1281US2024360174A1Cell-penetrating peptide sequencesOHIO STATE INNOVATION FOUNDATION·Filed 2024·Application pending·0 cites
- 1378US2025353814A1Non-peptidic cell-penetrating motifsOHIO STATE INNOVATION FOUNDATION·Filed 2025·Application pending·0 cites
- 1477US12404236B2Non-peptidic cell-penetrating motifsOHIO STATE INNOVATION FOUNDATION·Filed 2023·Granted Sep 2, 2025·0 cites·16 claims
- 1574US2022177523A1Cell penetrating peptides and methods of making and using thereofENTRADA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1671US2025090675A1Polypeptide conjugates for intracellular delivery of nucleic acidsOHIO STATE INNOVATION FOUNDATION·Filed 2024·Application pending·0 cites
- 1769US11814341B2Non-peptidic cell-penetrating motifsOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Nov 14, 2023·0 cites·17 claims
- 1866US2025011774A1Antisense compounds and methods for targeting cug repeatsENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1961US2024417429A1Compositions and methods for skipping exon 45 in duchenne muscular dystrophyENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2060US12171838B2Polypeptide conjugates for intracellular delivery of nucleic acidsOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Dec 24, 2024·0 cites·20 claims
- 2160US2025289851A1Cyclic peptides for delivering therapeuticsENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2259US2025228953A1Intracellular targeting of oligonucleotidesENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2359US2024245790A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2458US12378267B2Synthesis of FMOC-protected morpholino monomers and oligomersENTRADA THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·20 claims
- 2558US2023312653A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2658US2025051393A1Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activityENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2758US2023027739A1Antigen-binding and antigen degradation constructsENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2857US2025051780A1COMPOSITIONS AND METHODS FOR MODULATING mRNA SPLICINGENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2957US2024358845A1Compositions and methods for intracellular therapeuticsENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3055US2024247259A1Compositions and methods for modulating gene expressionENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3154US2025243244A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3251US10456443B2Peptidyl calcineurin inhibitorsOHIO STATE INNOVATION FOUNDATION·Filed 2015·Granted Oct 29, 2019·0 cites·9 claims
- 3349US2023020092A1Compositions for delivery of antisense compoundsENTRADA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3447US2019309020A1Cell-penetrating peptide sequencesOHIO STATE INNOVATION FOUNDATION·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ziqing Qian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →